Portfolio company
Annaida
Switzerland · £1.0m raised
Raised
£1.0m
Latest stage
Seed
Rounds recorded
1
Backed by
5 investors
Sectors
About
Annaida Technologies develops non-invasive microscopic magnetic resonance spectroscopy devices for embryo screening and metabolic analysis in fertility clinics and life science research laboratories.
SourceFunding history · 1
Similar companies
Imvitro
Imvitro develops an artificial intelligence platform for embryo selection to help fertility clinics improve success rates and transparency for IVF patients.
DeepSpin
DeepSpin develops portable, AI-powered magnetic resonance imaging systems for hospitals, clinics and ambulatory care providers to improve medical diagnostics.
Future Fertility
This company develops artificial intelligence software for oocyte quality assessment to assist fertility clinics and patients with reproductive treatment decisions.
numares AG
This company develops nuclear magnetic resonance diagnostic systems and metabolite-based tests for clinical laboratories and life science researchers.
Adialante
Adialante develops mobile magnetic resonance imaging systems for medical clinics to enable accessible cancer screening.
Bionomous
Bionomous develops automated AI-powered systems that screen, sort and plate small biological entities for research laboratories in life sciences, aquaculture and agriculture.
Fairtility
Fairtility develops artificial intelligence software for embryo assessment and clinical decision support to help fertility clinics and embryologists improve outcomes.
Endometrics
Endometrics develops non-invasive diagnostic tests using menstrual blood samples and genomic biomarkers to detect endometriosis for women and healthcare providers.
